60
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      mGluR5 positive allosteric modulators facilitate both hippocampal LTP and LTD and enhance spatial learning

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Highly selective positive allosteric modulators (PAMs) of metabotropic glutamate receptor subtype 5 (mGluR5) have emerged as a potential approach to treat positive symptoms associated with schizophrenia. mGluR5 plays an important role in both long term potentiation (LTP) and long term depression (LTD), suggesting that mGluR5 PAMs may also have utility in improving impaired cognitive function. However, if mGluR5 PAMs shift the balance of LTP and LTD or induce a state in which afferent activity induces lasting changes in synaptic function that are not appropriate for a given pattern of activity, this could disrupt rather than enhance cognitive function. We determined the effect of selective mGluR5 PAMs on induction of LTP and LTD at the Schaffer collateral – CA1 synapse in the hippocampus. mGluR5-selective PAMs significantly enhanced threshold theta burst stimulation (TBS)-induced LTP. In addition, mGluR5 PAMs enhanced both DHPG-induced LTD and LTD induced by delivery of paired-pulse low frequency stimulation. Selective potentiation of mGluR5 had no effect on LTP induced by suprathreshold TBS or saturated LTP. The finding that potentiation of mGluR5-mediated responses to stimulation of glutamatergic afferents enhances both LTP and LTD supports the hypothesis that activation of mGluR5 by endogenous glutamate contributes to both forms of plasticity. Furthermore, two systemically active mGluR5 PAMs enhanced performance in the Morris water maze, a measure of hippocampus-dependent spatial learning. Discovery of small molecules that enhance both LTP and LTD in an activity-appropriate manner demonstrates a unique action on synaptic plasticity that may provide a novel approach for treatment of impaired cognitive function.

          Related collections

          Most cited references87

          • Record: found
          • Abstract: found
          • Article: not found

          Pharmacology and functions of metabotropic glutamate receptors.

          P Conn, J P Pin (1997)
          In the mid to late 1980s, studies were published that provided the first evidence for the existence of glutamate receptors that are not ligand-gated cation channels but are coupled to effector systems through GTP-binding proteins. Since those initial reports, tremendous progress has been made in characterizing these metabotropic glutamate receptors (mGluRs), including cloning and characterization of cDNA that encodes a family of eight mGluR subtypes, several of which have multiple splice variants. Also, tremendous progress has been made in developing new highly selective mGluR agonists and antagonists and toward determining the physiologic roles of the mGluRs in mammalian brain. These findings have exciting implications for drug development and suggest that the mGluRs provide a novel target for development of therepeutic agents that could have a significant impact on neuropharmacology.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders.

            Despite G-protein-coupled receptors (GPCRs) being among the most fruitful targets for marketed drugs, intense discovery efforts for several GPCR subtypes have failed to deliver selective drug candidates. Historically, drug discovery programmes for GPCR ligands have been dominated by efforts to develop agonists and antagonists that act at orthosteric sites for endogenous ligands. However, in recent years, there have been tremendous advances in the discovery of novel ligands for GPCRs that act at allosteric sites to regulate receptor function. These compounds provide high selectivity, novel modes of efficacy and may lead to novel therapeutic agents for the treatment of multiple psychiatric and neurological human disorders.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Chemical induction of mGluR5- and protein synthesis--dependent long-term depression in hippocampal area CA1.

              Recent work has demonstrated that specific patterns of synaptic stimulation can induce long-term depression (LTD) in area CA1 that depends on activation of metabotropic glutamate receptors (mGluRs) and rapid protein synthesis. Here we show that the same form of synaptic modification can be induced by brief application of the selective mGluR agonist (RS)-3,5-dihydroxyphenylglycine (DHPG). DHPG-LTD 1) is a saturable form of synaptic plasticity, 2) requires mGluR5, 3) is mechanistically distinct from N-methyl-D-aspartate receptor (NMDAR)--dependent LTD, and 4) shares a common expression mechanism with protein synthesis-dependent LTD evoked using synaptic stimulation. DHPG-LTD should be useful for biochemical analysis of mGluR5- and protein synthesis-dependent synaptic modification.
                Bookmark

                Author and article information

                Journal
                8904907
                1376
                Neuropsychopharmacology
                Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
                0893-133X
                1740-634X
                25 February 2009
                18 March 2009
                August 2009
                14 June 2010
                : 34
                : 9
                : 2057-2071
                Affiliations
                [1 ]Department of Pharmacology, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
                [2 ]Brain Institute, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
                [3 ]Vanderbilt Program in Drug Discovery, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
                [4 ]Vanderbilt Institute for Chemical Biology, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
                [5 ]Department of Chemistry, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
                [6 ]Center for Drug and Alcohol Programs, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, South Carolina, USA.
                Author notes
                Corresponding author contact information: P. Jeffrey Conn, Ph.D., Department of Pharmacology, Vanderbilt University Medical Center, 1215D Light Hall, 2215-B Garland Avenue, Nashville, TN 37232-6600, Phone: (615)-936-2478, Fax: (615) 343-3088, jeffrey.conn@ 123456vanderbilt.edu
                [*]

                These authors contributed equally.

                Yelin Chen present address: The Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139

                Jessica L. Banko present address: College of Medicine Office of Research, University of South Florida, Tampa, FL 33612.

                Article
                nihpa93481
                10.1038/npp.2009.30
                2884290
                19295507
                5060b391-166b-44d8-a991-bd1d4dbd96a8
                History
                Funding
                Funded by: National Institute of Mental Health : NIMH
                Award ID: R01 MH062646-08 ||MH
                Categories
                Article

                Pharmacology & Pharmaceutical medicine
                synaptic plasticity,group i mglur,mglur5,ltd,allosteric potentiator,ltp

                Comments

                Comment on this article